Amgen Inc.

NasdaqGS:AMGN

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

💉 Vaccines

Location

United States

Market Cap

USD 159.23 B

Share Price

USD 295.76

Avg Daily Volume

2,405,924

Change (1 day)

-0.23%

Change (1 year)

-10.14%

Change (YTD)

13.48%

Amgen Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending December 31, 2019: 12.93%

Amgen Inc. Return on Assets (ROA) is 12.93% for the Trailing 12 Months (TTM) ending December 31, 2019. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Competitors

Eli Lilly and Company

USD 709.82

LLY

+4.38 0.62%

AbbVie Inc.

USD 209.50

ABBV

+0.35 0.17%

Roche Holding AG

USD 339.30

RO.SW

-2.14 -0.63%

Novartis AG

USD 127.19

NOVN.SW

-0.09 -0.07%

Novo Nordisk A/S

USD 55.23

NOVO-B.CO

+1.42 2.64%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Merck & Co., Inc.

USD 86.08

MRK

+1.42 1.68%

Thermo Fisher Scientific Inc.

USD 483.76

TMO

-11.05 -2.23%

Pfizer Inc.

USD 25.74

PFE

+0.36 1.42%

Gilead Sciences, Inc.

USD 116.14

GILD

-2.59 -2.18%

Sanofi

USD 101.52

SAN.PA

+0.13 0.13%

Vertex Pharmaceuticals Incorporated

USD 397.46

VRTX

+3.10 0.79%

Bristol-Myers Squibb Company

USD 48.43

BMY

+0.17 0.35%

Chugai Pharmaceutical Co., Ltd.

USD 42.04

4519.T

-0.42 -0.99%

Regeneron Pharmaceuticals, Inc.

USD 598.16

REGN

+7.15 1.21%

View all

Key Data

Date	Return on Assets (ROA)	Revenue Per Share	Free Cash Flow Per Share	Dividend Per Share